Roivant

Bio & Pharma S.Korea’s SK to buy US bio JV stake from Roivant for $48 mn

SK Group, South Korea’s second-largest conglomerate, is set to purchase the entire stake in a US bio joint venture held by its partner, as the...

Drug development SK injects $200 mn into Roivant partnership for new drug development

SK Holdings Co., the holding company of South Korean conglomerate SK Group, has become the first Korean company to foray into the targeted protein d...